Health & TechThe FDA approved the first disease-modifying drug for Alexander disease
Zanvastro (zilganersen) is approved for a rare, often fatal brain disorder. In a controlled trial, treated patients 5 and older with walking trouble were faster at 61 weeks, and treated 2- to 4-year-olds gained motor skills while untreated children declined. It is not a cure.
Verified · Nature Biotechnology





